title: Androgen induces differentiation of a human papillomavirus 16 E6/E7 immortalized prostate epithelial cell line.
abstract: Androgen signaling is crucial for the growth and development, as well as for tumorigenesis of the prostate. However, many of the prostate epithelial cell lines developed previously, either normal or tumorigenic, do not express androgen receptor (AR) or respond to androgen. In order to advance our understanding on how androgen signaling regulates the growth and the differentiation status, and affects tumorigenicity of the epithelial cell, we performed experiments on HPr-1, a prostate cell line recently immortalized from normal human prostate epithelial cells. In the present study, AR was stably transfected into HPr-1 cells by replication-defective retrovirus. Treatment of HPr-1AR cells with androgen resulted in cell differentiation and growth retardation accompanied with up-regulation of cytokeratins K8 and K18, prostate specific antigen, p21 and p27, and down-regulation of c-myc, bcl-2 and telomerase activity. Our results suggest that androgen promotes the process of differentiation in a human papillomavirus 16 E6/E7 immortalized prostate epithelial cell line which may reflect the normal effects of androgen on prostate cells.
authors: Department of Pathology, The University of Hong Kong, Hong Kong.
authors: M T
authors: MT
authors: Ling
authors: K W
authors: KW
authors: Chan
authors: C K
authors: CK
authors: Choo
mesh_terms: D000728:Androgens / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002461:Cell Line, Transformed / Q000187:drug effects*; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins / Q000378:metabolism; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007633:Keratins / Q000378:metabolism; D008297:Male; D008840:Microfilament Proteins / Q000378:metabolism; D009124:Muscle Proteins; D027383:Papillomaviridae; D011467:Prostate / Q000166:cytology / Q000187:drug effects*; D017430:Prostate-Specific Antigen / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000628:therapy; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D016271:Proto-Oncogene Proteins c-myc / Q000378:metabolism; D011944:Receptors, Androgen / Q000235:genetics*; D013268:Stimulation, Chemical; D019098:Telomerase / Q000378:metabolism; D014162:Transfection / Q000379:methods; D051028:bcl-2-Associated X Protein
chemical_list: D000728:Androgens; C493956:CDKN1A protein, human; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins; D008840:Microfilament Proteins; D009124:Muscle Proteins; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D016271:Proto-Oncogene Proteins c-myc; D011944:Receptors, Androgen; C058992:Tagln protein, mouse; D051028:bcl-2-Associated X Protein; D007633:Keratins; D019098:Telomerase; D017430:Prostate-Specific Antigen